Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Objective criteria for crohn-like lymphoid reaction in colorectal cancer.

Ueno H, Hashiguchi Y, Shimazaki H, Shinto E, Kajiwara Y, Nakanishi K, Kato K, Maekawa K, Miyai K, Nakamura T, Yamamoto J, Hase K.

Am J Clin Pathol. 2013 Apr;139(4):434-41. doi: 10.1309/AJCPWHUEFTGBWKE4.

PMID:
23525613
2.

Comparative validation of assessment criteria for Crohn-like lymphoid reaction in colorectal carcinoma.

Kim JH, Kim KJ, Bae JM, Rhee YY, Cho NY, Lee HS, Kang GH.

J Clin Pathol. 2015 Jan;68(1):22-8. doi: 10.1136/jclinpath-2014-202603. Epub 2014 Oct 16.

PMID:
25322692
3.

Characteristics and significance of colorectal cancer associated lymphoid reaction.

Väyrynen JP, Sajanti SA, Klintrup K, Mäkelä J, Herzig KH, Karttunen TJ, Tuomisto A, Mäkinen MJ.

Int J Cancer. 2014 May 1;134(9):2126-35. doi: 10.1002/ijc.28533. Epub 2013 Oct 24.

4.

Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.

Rozek LS, Schmit SL, Greenson JK, Tomsho LP, Rennert HS, Rennert G, Gruber SB.

J Natl Cancer Inst. 2016 May 12;108(8). doi: 10.1093/jnci/djw027. Print 2016 Aug.

5.

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman WH, Pagès F, Galon J.

J Clin Oncol. 2011 Feb 20;29(6):610-8. doi: 10.1200/JCO.2010.30.5425. Epub 2011 Jan 18.

PMID:
21245428
6.

Prognostic impact of B-cell density in cutaneous melanoma.

Ladányi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejös Z, Gaudi I, Dobos J, Tímár J.

Cancer Immunol Immunother. 2011 Dec;60(12):1729-38. doi: 10.1007/s00262-011-1071-x. Epub 2011 Jul 21.

PMID:
21779876
7.

Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis.

Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, Fleuren GJ, Kuppen PJ.

Lab Invest. 2004 Apr;84(4):493-501.

8.

T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.

Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, Gonen M, Jarnagin W, Fong Y, Blumgart L, D'Angelica M, DeMatteo RP.

Ann Surg Oncol. 2009 Sep;16(9):2524-30. doi: 10.1245/s10434-009-0585-3. Epub 2009 Jul 1.

PMID:
19568816
9.

Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.

Correale P, Rotundo MS, Botta C, Del Vecchio MT, Ginanneschi C, Licchetta A, Conca R, Apollinari S, De Luca F, Tassone P, Tagliaferri P.

Clin Cancer Res. 2012 Feb 1;18(3):850-7. doi: 10.1158/1078-0432.CCR-10-3186. Epub 2011 Dec 5.

10.

BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.

Kalady MF, Dejulius KL, Sanchez JA, Jarrar A, Liu X, Manilich E, Skacel M, Church JM.

Dis Colon Rectum. 2012 Feb;55(2):128-33. doi: 10.1097/DCR.0b013e31823c08b3.

PMID:
22228154
11.

The value of immunohistochemistry for collagen IV expression in colorectal carcinomas.

Offerhaus GJ, Giardiello FM, Bruijn JA, Stijnen T, Molyvas EN, Fleuren GJ.

Cancer. 1991 Jan 1;67(1):99-105.

PMID:
1985727
12.

Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases.

Barresi V, Reggiani Bonetti L, Vitarelli E, Di Gregorio C, Ponz de Leon M, Barresi G.

Am J Surg Pathol. 2012 Jan;36(1):66-72. doi: 10.1097/PAS.0b013e31822d3008.

PMID:
21989343
13.

Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer.

Huh JW, Lee JH, Kim HR.

Arch Surg. 2012 Apr;147(4):366-72. doi: 10.1001/archsurg.2012.35.

PMID:
22508783
14.

Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study.

Stender MT, Larsen TB, Sørensen HT, Thorlacius-Ussing O.

J Thromb Haemost. 2012 Oct;10(10):2027-31. doi: 10.1111/j.1538-7836.2012.04887.x.

15.

Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.

Petraki C, Dubinski W, Scorilas A, Saleh C, Pasic MD, Komborozos V, Khalil B, Gabril MY, Streutker C, Diamandis EP, Yousef GM.

Pathol Res Pract. 2012 Feb 15;208(2):104-8. doi: 10.1016/j.prp.2011.12.010. Epub 2012 Jan 28.

PMID:
22285222
16.

Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.

Oshikiri T, Miyamoto M, Morita T, Fujita M, Miyasaka Y, Senmaru N, Yamada H, Takahashi T, Horita S, Kondo S.

Clin Cancer Res. 2006 Jan 15;12(2):411-6.

17.

CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.

Kawamura M, Toiyama Y, Tanaka K, Saigusa S, Okugawa Y, Hiro J, Uchida K, Mohri Y, Inoue Y, Kusunoki M.

Eur J Cancer. 2012 Sep;48(14):2244-51. doi: 10.1016/j.ejca.2011.11.032. Epub 2011 Dec 24.

PMID:
22197219
18.

Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases.

Nascimbeni R, Di Fabio F, Di Betta E, Mariani P, Fisogni S, Villanacci V.

Mod Pathol. 2005 May;18(5):681-5.

19.

The impact of preoperative immunonutrition and other nutrition models on tumor infiltrative lymphocytes in colorectal cancer patients.

Caglayan K, Oner I, Gunerhan Y, Ata P, Koksal N, Ozkara S.

Am J Surg. 2012 Oct;204(4):416-21. doi: 10.1016/j.amjsurg.2011.12.018.

PMID:
23010614
20.

Supplemental Content

Support Center